斑块切除设备市场：市场规模（按细分市场）、份额、监管、报销、程序、预测（~2033）

冠状动脉疾病（CAD）正在成为发展中国家和已开发国家的全球负担。週边动脉疾病（PAD）是一个全球性的公共卫生和社会经济问题，每年影响数百万患者。由于糖尿病、高血压、肥胖和吸烟等危险因子和合併症，全世界 CAD 和 PAD 的盛行率正在增加。

整体而言，都市化导致吸烟率上升、缺乏身体活动和不健康的生活方式。此外，老年人口的增长也导致疾病盛行率上升，因为许多合併症与年龄密切相关。

该报告深入探讨了全球旋切设备市场，包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。

目录

目前市面上的旋切设备及竞争状况

• 洞察关键产业趋势
• 2015年至2033年斑块切除设备各细分市场的市场总收入及市场前景
• 按细分市场划分的程序总数、单位数、平均售价和市场价值的详细数据

全球、区域和国家见解

• 斑块切除设备市场的 SWOT 分析
• 斑块切除设备市场的竞争动态洞察与趋势
• 按国家/地区划分的医疗保健系统概览
• 各国报销政策
• 各国医疗技术法规现状

Abstract

Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Atherectomy Devices market for the year 2020 and beyond. Coronary Artery Disease (CAD) has emerged as a global burden on developing and developed countries. Peripheral artery disease (PAD) is a global public health and socioeconomic problem affecting millions of patients each year. The increasing prevalence of both CAD and PAD worldwide can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use.

Overall, urbanization has led to increased smoking rates, lack of physical activity and unhealthy lifestyle. Moreover, as many of these comorbidities are closely tied to age, the growing elderly population will also contribute to the rising disease prevalence.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Atherectomy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Atherectomy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Atherectomy Devices market.
• Competitive dynamics insights and trends provided for Atherectomy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Cardiovascular Systems Inc, Boston Scientific Corp, Koninklijke Philips NV, Medtronic Plc, Avinger Inc, Becton Dickinson and Co, Angiodynamics Inc.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Atherectomy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Atherectomy Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Atherectomy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Atherectomy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Atherectomy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable